Drug Design, Development and Therapy (Apr 2017)

Decitabine reverses TGF-β1-induced epithelial–mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis [Corrigendum]

  • Zhang N,
  • Liu Y,
  • Wang Y,
  • Zhao M,
  • Tu L,
  • Luo F

Journal volume & issue
Vol. Volume 11
pp. 1161 – 1162

Abstract

Read online

Zhang N, Liu Y, Wang Y, Zhao M, Tu L, Luo F. Drug Des Devel Ther. 2017;11:969–983.Throughout the paper, including Figures, an abbreviation has been defined incorrectly. TGF-β1 was incorrectly defined ‘tumor growth factor-beta 1’. The correct definition for TGF-β1 is ‘transforming growth factor-beta 1’.Read the original article